Mineral metabolism disturbances and arteriovenous fistula maturation
Mineral metabolism disturbances and arteriovenous fistula maturation
批准号:
8436693
负责人:
BRYAN R KESTENBAUM
金额:
$33.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-09-28 至 2015-08-31
关键词:
1,25 (OH) vitamin D25-hydroxyvitamin DAffectAmericanApplications GrantsArteriesArteriosclerosisArteriovenous fistulaBiological MarkersBlood VesselsBlood flowCalcifiedCaliberCathetersCell Culture TechniquesCellsCessation of lifeChronicChronic DiseaseChronic Kidney FailureClinicalDialysis patientsDialysis procedureDihydroxycholecalciferolsElectric CapacitanceEnd stage renal failureEnvironmentFailureFistulaFunctional disorderFutureGenesGoldHemodialysisHistologicHormonesHospitalizationHyperplasiaHypertensionIncidenceIndividualInfectionInflammationInflammatoryInterventionKidneyKidney DiseasesKidney FailureKidney TransplantationLaboratoriesLesionLifeLinkMass Spectrum AnalysisMeasurementMeasuresMedialMediatingMetabolicMetabolic DiseasesMetabolismMethodsMineralsModelingNational Institute of Diabetes and Digestive and Kidney DiseasesOperative Surgical ProceduresOsteoblastsOutcomeParathyroid glandPathway interactionsPatientsPhosphorusPhysiologic pulsePhysiologicalPostoperative PeriodPreventionProcessProspective StudiesRenin-Angiotensin SystemResearchRiskRisk FactorsRoleSamplingSeriesSerumSmooth MuscleSurgical AnastomosisTechniquesTestingTherapeutic InterventionThrombosisTissuesUnited StatesVascular calcificationVasodilationVeinsVenousVitamin Darterial stiffnessbrachial arterycalcificationcardiovascular disorder riskcytokinedesignfeedingfibroblast growth factor 23follow-upimprovedmetabolomicsnovelnovel markerprematureprospectiveresearch studyresponsetherapy design
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): More than 450,000 Americans have end stage kidney disease (ESKD), which requires dialysis or kidney transplantation for survival. The artriovenous fistula (AVF) represents a lifeline for hemodialysis patients because it offers substantially lower
rates of infections and hospitalizations, and improved survival compared to other vascular access methods, such as artriovenous grafts or dialysis catheters. Unfortunately, as many as 50% of AVFs fail to mature within the toxic metabolic environment of kidney failure. Disturbances in mineral metabolism, which are common among ESKD patients, may be novel causes of AVF maturation failure. Early kidney disease leads to phosphorus retention, which is connected with arterial calcification in cell culture models and in individuals who have ESKD. Vascular calcification may contribute to AVF maturation failure through increased vessel stiffness and the prevention of adequate vasodilation in response to increased blood flow. Kidney dysfunction also leads to impaired vitamin D activation, which may interfere with successful AVF maturation by activating genes related to inflammation, hypertension, and thrombosis. The purpose of this application is to comprehensively evaluate associations of mineral metabolism markers with AVF maturation failure and vascular dysfunction within an established prospective study. We propose to add 6 mineral metabolism measurements to the Hemodialysis Fistula Maturation Consortium study: fibroblast growth factor-23, phosphorus, 25-hydroxyvitamin D, 24,25-dihydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone. We will evaluate associations of these markers with clinical AVF maturation, longitudinal changes in blood flow and vessel diameter, and cross sectional differences in endothelial function, arterial stiffness, venous compliance, and calcification. The proposed research is designed to provide credible evidence that mineral metabolism disorders contribute to vascular dysfunction and AVF maturation and suggest potential targets for future interventions designed to improve AVF maturation rates.
PUBLIC HEALTH RELEVANCE: The purpose of this grant application is to add measurements of mineral metabolism biomarkers to the ongoing Hemodialysis Fistula Maturation Consortium study and to evaluate whether these markers are associated with fistula maturation and vascular dysfunction. Mineral metabolism measurements will be performed using gold- standard laboratory techniques and vascular function studies will be carried out using standardized methods. The studies proposed in this application are intended to discover new markers of fistula maturation in patients who have end stage kidney disease and to suggest possible targets for future trials.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of Kidney Proximal Tubular Secretion in Critical Illness
-
批准号:10398127
-
项目类别:
-
资助金额:$68.67万
-
财政年份:2020
-
负责人:BRYAN R KESTENBAUM
-
依托单位:
Kidney Tubular Functions in Type 1 Diabetes
-
批准号:10449358
-
项目类别:
-
资助金额:$64.09万
-
财政年份:2020
-
负责人:BRYAN R KESTENBAUM
-
依托单位:
Kidney Tubular Functions in Type 1 Diabetes
-
批准号:10264925
-
项目类别:
-
资助金额:$64.52万
-
财政年份:2020
-
负责人:BRYAN R KESTENBAUM
-
依托单位:
Role of Kidney Proximal Tubular Secretion in Critical Illness
-
批准号:10217335
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2020
-
负责人:BRYAN R KESTENBAUM
-
依托单位:
Kidney Tubular Functions in Type 1 Diabetes
-
批准号:10668298
-
项目类别:
-
资助金额:$65.64万
-
财政年份:2020
-
负责人:BRYAN R KESTENBAUM
-
依托单位:
Role of Kidney Proximal Tubular Secretion in Critical Illness
-
批准号:9916616
-
项目类别:
-
资助金额:$70.23万
-
财政年份:2020
-
负责人:BRYAN R KESTENBAUM
-
依托单位:
Role of Kidney Proximal Tubular Secretion in Critical Illness
-
批准号:10620671
-
项目类别:
-
资助金额:$67.13万
-
财政年份:2020
-
负责人:BRYAN R KESTENBAUM
-
依托单位:
Tubular Secretion in Chronic Kidney Disease
-
批准号:9008641
-
项目类别:
-
资助金额:$73.24万
-
财政年份:2016
-
负责人:BRYAN R KESTENBAUM
-
依托单位:
Midcareer Investigator Award: Metabolic Complications of Chronic Kidney Disease
-
批准号:9901518
-
项目类别:
-
资助金额:$12.68万
-
财政年份:2016
-
负责人:BRYAN R KESTENBAUM
-
依托单位:
Mineral metabolism disturbances and arteriovenous fistula maturation
-
批准号:8549212
-
项目类别:
-
资助金额:$29.18万
-
财政年份:2012
-
负责人:BRYAN R KESTENBAUM
-
依托单位:
Serum Calcification Activity in Patients with Chronic Kidney Disease
-
批准号:8185209
-
项目类别:
-
资助金额:$23.12万
-
财政年份:2011
-
负责人:BRYAN R KESTENBAUM
-
依托单位:
Serum Calcification Activity in Patients with Chronic Kidney Disease
-
批准号:8332141
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2011
-
负责人:BRYAN R KESTENBAUM
-
依托单位:
Phosphorus and Vitamin D Metabolism and Cardiovascular Outcomes: The MESA Study
-
批准号:8250476
-
项目类别:
-
资助金额:$51.21万
-
财政年份:2010
-
负责人:BRYAN R KESTENBAUM
-
依托单位:
Phosphorus and Vitamin D Metabolism and Cardiovascular Outcomes: The multi-ethni
-
批准号:7889294
-
项目类别:
-
资助金额:$78.0万
-
财政年份:2010
-
负责人:BRYAN R KESTENBAUM
-
依托单位:
Individual response to vitamin D treatment
-
批准号:9103518
-
项目类别:
-
资助金额:$79.22万
-
财政年份:2010
-
负责人:BRYAN R KESTENBAUM
-
依托单位:
Phosphorus and Vitamin D Metabolism and Cardiovascular Outcomes: The multi-ethni
-
批准号:8075537
-
项目类别:
-
资助金额:$77.01万
-
财政年份:2010
-
负责人:BRYAN R KESTENBAUM
-
依托单位:
Phosphorus and Vitamin D Metabolism and Cardiovascular Outcomes: The MESA Study
-
批准号:8448210
-
项目类别:
-
资助金额:$48.48万
-
财政年份:2010
-
负责人:BRYAN R KESTENBAUM
-
依托单位:
Mineral Metabolism and Cardiovascular Risk among Older Adults
-
批准号:7845197
-
项目类别:
-
资助金额:$24.34万
-
财政年份:2009
-
负责人:BRYAN R KESTENBAUM
-
依托单位:
Mineral Metabolism and Cardiovascular Risk among Older Adults
-
批准号:7317846
-
项目类别:
-
资助金额:$51.1万
-
财政年份:2007
-
负责人:BRYAN R KESTENBAUM
-
依托单位:
Mineral Metabolism and Cardiovascular Risk among Older Adults
-
批准号:7630412
-
项目类别:
-
资助金额:$31.6万
-
财政年份:2007
-
负责人:BRYAN R KESTENBAUM
-
依托单位:
海外基金